GPC3 and colonic neoplasm: Hou et al. [121] adopted PDT to select novel binding peptides for early colon cancer imaging detection and found a peptide termed CBP-DWS, which was demonstrated to be capable of binding to a panel of human colon cancer cell lines and tissues by targeting glypican-3.